Profiles

Keywords
Last Name
Institution

Connection

Search Results to Timothy Kuzel

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Kuzel, Timothy

Item TypeName
Concept Antineoplastic Combined Chemotherapy Protocols
Concept Drug Therapy, Combination
Concept Chemotherapy, Adjuvant
Academic Article Monoclonal antibody therapy of lymphoproliferative disorders.
Academic Article Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma.
Academic Article Interferon alfa-2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma.
Academic Article Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy.
Academic Article Metastatic bladder cancer: advances in treatment.
Academic Article Multicenter phase II trial of interleukin-2, interferon-alpha, and 13-cis-retinoic acid in patients with metastatic renal-cell carcinoma.
Academic Article Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer.
Academic Article HTLV-I associated leukemia/lymphoma: epidemiology, biology, and treatment.
Academic Article Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): a trial of the Eastern Cooperative Oncology Group.
Academic Article A multi-institutional phase II trial of a novel inpatient schedule of continuous interleukin-2 with interferon alpha-2b in advanced renal cell carcinoma: major durable responses in a less highly selected patient population.
Academic Article Human T-cell lymphotropic-I-associated leukemia/lymphoma.
Academic Article Phase I trial of oral estramustine and 3-hr infusional paclitaxel for the treatment of hormone refractory prostate cancer.
Academic Article Secondary cutaneous anaplastic large cell lymphoma treated with liposomal doxorubicin (Doxil) leading to complete remission.
Academic Article Systemic chemotherapy for the treatment of mycosis fungoides and Sézary syndrome.
Academic Article High-dose therapy and bone marrow transplantation in cutaneous T-cell lymphoma.
Academic Article A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer.
Academic Article A pilot trial of rituximab and alemtuzumab combination therapy in patients with relapsed and/or refractory chronic lymphocytic leukemia (CLL).
Academic Article Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project.
Academic Article Results of a phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma.
Academic Article Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
Academic Article Bladder cancer.
Academic Article NCCN clinical practice guidelines in oncology: kidney cancer.
Academic Article Bladder cancer. Clinical practice guidelines in oncology.
Academic Article Testicular cancer. Clinical practice guidelines.
Academic Article Safety and efficacy of PF-3512676 for the treatment of stage IV renal cell carcinoma: an open-label, multicenter phase I/II study.
Academic Article A pilot study of denileukin diftitox (DD) in combination with high-dose interleukin-2 (IL-2) for patients with metastatic renal cell carcinoma (RCC).
Academic Article Renal cell carcinoma and acute promyelocytic leukemia: a nonrandom association?
Academic Article Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphoma.
Academic Article Bladder cancer.
Academic Article Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial.
Academic Article The Efficacy of Lenvatinib and Everolimus in Chromophobe-type Non-Clear-Cell Renal Cell Carcinoma: A Case Report and Literature Review.
Academic Article NCI 8628: A randomized phase 2 study of ziv-aflibercept and high-dose interleukin 2 or high-dose interleukin 2 alone for inoperable stage III or IV melanoma.

Search Criteria
  • Drug Therapy